Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection

Leukemia Research

Volumn 29, Issue 2, 2005, Pages 159-163

  Corso, Alessandro ^a   Varettoni, Marzia ^a   Mangiacavalli, Silvia ^a   Zappasodi, Patrizia ^a   Klersy, Catherine ^a   Rusconi, Chiara ^a   Colucci, Emile ^a   Lorenzi, Angela ^a   Troletti, Daniela ^a   Consensi, Erica ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

CD34+ cells; Lymphoma; Multiple myeloma; Peripheral stem cell collection; Transplant

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CD34 ANTIGEN; GROWTH FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; LEUKAPHERESIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PREDICTION; PRIORITY JOURNAL; STEADY STATE;

ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; BONE MARROW CELLS; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS;

EID: 10644288561     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.05.018     Document Type: Article

References (24)

1. M. Attal, J.L. Harousseau, and A.M. Stoppa A prospective, randomised trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome N Engl J Med 335 1996 91 97
2. B. Barlogie, S. Jagannath, and D. Vesole Superiority of tandem autologous transplantation over standard therapy of previously untreated multiple myeloma Blood 89 1997 789 793
3. M.A. Shipp, M.D. Abeloff, and K.H. Antman International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury J Clin Oncol 17 1999 423 429
4. A.K. Burnett, A.H. Goldstone, and R.M. Stevens Randomised comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial Lancet 351 1998 700 708
5. A. Gratwohl, J. Passweg, H. Baldomero, and J. Hermans Blood and marrow transplantation activity in Europe 1997: European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 24 1999 231
6. W.I. Bensinger, F. Appelbaum, and S. Rowley Factors that influence collection and engraftment of autologous peripheral blood stem cells J Clin Oncol 13 1995 2547 2555
7. C.H. Weaver, B. Hazelton, and R. Birch An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy Blood 86 1995 3961 3969
8. G. Tricot, S. Jagannath, and D. Vesole Peripheral blood stem cell transplants for multiple myeloma: identification of favourable variables for rapid engraftment in 225 patients Blood 85 1995 588 596
9. J.A. Perez-Simon, A. Martin, and D. Caballero Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 24 1999 1279 1283
10. -1 CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation Bone Marrow Transplant 23 1 1999 9 13
11. F. Lefrre, R. Delarue, and D. Somme High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose Transfusion 42 2002 443 450
12. A. Corso, S. Caberlon, and G. Pagnucco Blood stem cell collection in multiple myeloma: definition of a scoring system Bone Marrow Transplant 26 2000 283 286
13. A. Corso, L. Arcaini, and S. Caberlon A combination of dexamethasone, cyclophosphamide, etoposide and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma Haematologica 87 2002 1041 1045
14. M.K. Gandhi, K. Jestice, and M.A. Scott The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients Bone Marrow Transplant 23 1999 9 13
15. T. Demirer, C.D. Buknener, and T. Gooley Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma Bone Marrow Transplant 17 1996 937 941
16. M. Drake, L. Ranaghan, and T.C.M. Morris Analysis of the effects of prior therapy on progenitor cell yield: use of a chemotherapy score system Br J Haematol 98 1997 745 749
17. R. Haas, R. Mhle, and S. Frhauf Patients characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma Blood 83 1994 3787 3794
18. N. Ketterer, G. Salles, and I. Moullet Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies Br J Haematol 103 1998 235 242
19. G. Perea, A. Sureda, and R. Martino Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma Ann Hematol 80 2001 592 597
20. M.A. Canales, M.C. Fernánde-Jimnez, and A. Martn Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease Haematologica 86 2001 494 498
21. S. Fruehauf, R. Haas, and C. Conradt Peripheral blood progenitor cell (PBPC) counts during steady-state hemtopoiesis allow to estimate the yield of mobilized PBPC after Filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy Blood 85 1995 2619 2626
22. M.M. Osma, F. Ortuño, and F. de Arriba Bone marrow steady-state CD34+/CD71- cell content is a predictive value of rG-CSF-mobilized CD34+ cells Blood 21 1998 983 985
23. L.M. Van Putten, P. Lelieveld, and L.K. Kram-Idsenga Cell-cycle specificity and therapeutic effectiveness of cytostatic agents Cancer Chemother Rep 56 6 1972 691 700
24. A. Corso, A. Lorenzi, and P. Zappasodi Early changes in bone marrow morphology induced by thalidomide in patients with refractory myeloma Haematologica 88 8 2003 958 960